CD8A and colon carcinoma: In this study, we designed DNA vaccines encoding multiple CD8+ T cell epitopes derived from the MC-38 colon carcinoma without (noHELP) or with universal- (uniHELP) or MC-38-derived (neoHELP) CD4+ T cell epitopes, and tested their immunogenicity and tumor control.